{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T04:53:46Z","timestamp":1776142426085,"version":"3.50.1"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1999,12]]},"DOI":"10.1093\/humrep\/14.12.2951","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T22:22:29Z","timestamp":1027722149000},"page":"2951-2958","source":"Crossref","is-referenced-by-count":20,"title":["Endocrine and metabolic effects of octreotide, a somatostatin analogue, in lean PCOS patients with either hyperinsulinaemia or lean normoinsulinaemia"],"prefix":"10.1093","volume":"14","author":[{"given":"Lilliana","family":"Ciotta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"De Leo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabiola","family":"Galvani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"La Marca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Cianci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[1999,12]]},"reference":[{"key":"key\n\t\t\t\t20170410032413_ADASHI-ETAL-1981","doi-asserted-by":"crossref","unstructured":"Adashi, E.Y., Hsueh, A.J.W. and Yen, S.S.C. (1981) Insulin enhancement of luteinizing hormone and follicle stimulating hormone release by cultured pituitary cells. Endocrinology, 108, 1441\u20131449.","DOI":"10.1210\/endo-108-4-1441"},{"key":"key\n\t\t\t\t20170410032413_BARBIERI-ETAL-1986","doi-asserted-by":"crossref","unstructured":"Barbieri, R.L., Makris, A., Randall, R.W. et al. (1986) Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism. J. Clin. Endocrinol. Metab., 62, 904\u2013910.","DOI":"10.1210\/jcem-62-5-904"},{"key":"key\n\t\t\t\t20170410032413_BARNES-AND-ROSENFIELD-1989","doi-asserted-by":"crossref","unstructured":"Barnes, R.B. and Rosenfield, R.L. (1989) Pituitary\u2013ovarian responses to nafarelin testing in the polycystic ovary syndrome. N. Engl. J. Med., 320, 559\u2013565.","DOI":"10.1056\/NEJM198903023200904"},{"key":"key\n\t\t\t\t20170410032413_BATES-AND-WHITWORTH-1982","doi-asserted-by":"crossref","unstructured":"Bates, G. and Whitworth, M.S. (1982) Effect of body weight reduction on plasma androgens in obese, infertile women. Fertil. Steril., 38, 406\u2013409.","DOI":"10.1016\/S0015-0282(16)46571-4"},{"key":"key\n\t\t\t\t20170410032413_BATHELMAI-AND-CZOK-1962","unstructured":"Bathelmai, W. and Czok, R. (1962) Enzymatic determinations of glucose in the blood, cerebrospinal fluid and urine. Klin. Wochensehr, 40, 585."},{"key":"key\n\t\t\t\t20170410032413_BURGHEN-ETAL-1980","doi-asserted-by":"crossref","unstructured":"Burghen, G.A., Givens, J.R. and Kitabchi, A.E. (1980) Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease. J. Clin. Endocrinol. Metab., 50, 113\u2013116.","DOI":"10.1210\/jcem-50-1-113"},{"key":"key\n\t\t\t\t20170410032413_CHANG-ETAL-1989","doi-asserted-by":"crossref","unstructured":"Chang, R.J., Nakamura, R.M., Judd, H.L. et al. (1989) Insulin resistance in nonobese patients with polycystic ovarian disease. J. Clin. Endocrinol. Metab., 57, 356\u2013359.","DOI":"10.1210\/jcem-57-2-356"},{"key":"key\n\t\t\t\t20170410032413_CIARALDI-ETAL-1992","unstructured":"Ciaraldi, T.P., El-Roeiy, A., Madar, Z. et al. (1992) Cellular mechanism of insulin resistance in polycystic ovary syndrome. J. Clin. Endocrinol. Metab., 75, 577\u2013583."},{"key":"key\n\t\t\t\t20170410032413_DALE-ETAL-1992A","doi-asserted-by":"crossref","unstructured":"Dale, P.O., Tambo, T., Vaaler, S. et al. (1992a) Body weight, hyperinsulinemia, and gonadotropin level in the polycystic ovary syndrome: evidence of two distinct populations. Fertil. Steril., 58, 487\u2013491.","DOI":"10.1016\/S0015-0282(16)55249-2"},{"key":"key\n\t\t\t\t20170410032413_DALE-ETAL-1992B","doi-asserted-by":"crossref","unstructured":"Dale, P.O., Tanbo, T., Djoseland, O. et al. (1992b) Persistence of hyperinsulinemia in polycystic ovary syndrome after ovarian suppression by gonadotropin-releasing hormone agonist. Acta Endocrinol. (Copenh.), 126, 132\u2013136.","DOI":"10.1530\/acta.0.1260132"},{"key":"key\n\t\t\t\t20170410032413_DE-FRONZO-ETAL-1991","doi-asserted-by":"crossref","unstructured":"De Fronzo, R.A., Barzilai, N. and Simonsom, D.C. (1991) Mechanism of metformin action in obese and lean noninsulin dependent diabetic subjects. J. Clin. Endocrinol. Metab., 73, 1294\u20131301.","DOI":"10.1210\/jcem-73-6-1294"},{"key":"key\n\t\t\t\t20170410032413_DUNAIF-ETAL-1987","doi-asserted-by":"crossref","unstructured":"Dunaif, A., Graf, M., Mandelli, J. et al. (1987) Characterization of groups of hyperandrogenic women with Acanthosis nigricans, impaired glucose tolerance, and\/or hyperinsulinemia. J. Clin. Endocrinol. Metab., 65, 499\u2013507.","DOI":"10.1210\/jcem-65-3-499"},{"key":"key\n\t\t\t\t20170410032413_DUNAIF-ETAL-1989","doi-asserted-by":"crossref","unstructured":"Dunaif, A., Segal, K.R., Futterweit, W. et al. (1989) Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes, 38, 1165\u20131174.","DOI":"10.2337\/diab.38.9.1165"},{"key":"key\n\t\t\t\t20170410032413_DUNAIF-ETAL-1990","doi-asserted-by":"crossref","unstructured":"Dunaif, A., Green, G., Futterweit, W. et al. (1990) Suppression of hyperandrogenism does not improve peripheral or hepatic insulin resistance in the polycystic ovary syndrome. J. Clin. Endocrinol. Metab., 70, 699\u2013704.","DOI":"10.1210\/jcem-70-3-699"},{"key":"key\n\t\t\t\t20170410032413_DUNAIF-ETAL-1992","doi-asserted-by":"crossref","unstructured":"Dunaif, A., Segal, K.R., Shelley, D.R. et al. (1992) Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome. Diabetes, 41, 1267\u20131266.","DOI":"10.2337\/diab.41.10.1257"},{"key":"key\n\t\t\t\t20170410032413_DUNAIF-ETAL-1995","doi-asserted-by":"crossref","unstructured":"Dunaif, A., Xia, J., Book, C.-B. et al. (1995) Excessive insulin receptor serine phosphorylation in cultured fibroblast and in skeletal muscle: a potential mechanism for insulin resistance in the polycystic ovary syndrome. J. Clin. Invest., 96, 801\u2013810.","DOI":"10.1172\/JCI118126"},{"key":"key\n\t\t\t\t20170410032413_DUNAIF-ETAL-1996","unstructured":"Dunaif, A., Scott, D., Finegood, D. et al. (1996) The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome. J. Clin. Endocrinol. Metab., 81, 3299\u20133306."},{"key":"key\n\t\t\t\t20170410032413_EHRMANN-ETAL-1992","doi-asserted-by":"crossref","unstructured":"Ehrmann, D.A., Rosenfield, R.L., Barnes, R.B. et al. (1992) Detection of functional ovarian hyperandrogenism in women with androgen excess. N. Engl. J. Med., 327, 157\u2013162.","DOI":"10.1056\/NEJM199207163270304"},{"key":"key\n\t\t\t\t20170410032413_EHRMANN-ETAL-1997","doi-asserted-by":"crossref","unstructured":"Ehrmann, D.A., Schneider, D.J., Burton, E. et al. (1997) Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab., 82, 2108\u20132116.","DOI":"10.1210\/jc.82.7.2108"},{"key":"key\n\t\t\t\t20170410032413_FERRIMAN-AND-GALLWEY-1961","doi-asserted-by":"crossref","unstructured":"Ferriman, D. and Gallwey, J.D. (1961) Clinical assessment of body hair growth in women. J. Clin. Endocrinol. Metab., 21, 1440\u20131447.","DOI":"10.1210\/jcem-21-11-1440"},{"key":"key\n\t\t\t\t20170410032413_FRANKS-1995","doi-asserted-by":"crossref","unstructured":"Franks, S. (1995) Polycystic ovary syndrome. N. Engl. J. Med., 333, 853\u2013861.","DOI":"10.1056\/NEJM199509283331307"},{"key":"key\n\t\t\t\t20170410032413_FULGHESU-ETAL-1995","doi-asserted-by":"crossref","unstructured":"Fulghesu, A.N., Lanzone, A., Andreani, C.L. et al. (1995) Effectiveness of a somatostatin analogue in lowering luteinizing hormone and insulin-stimulated secretion in hyperinsulinemic women with polycystic ovary disease. Fertil. Steril., 64, 703\u2013708.","DOI":"10.1016\/S0015-0282(16)57842-X"},{"key":"key\n\t\t\t\t20170410032413_GEISTHOVEL-ETAL-1996","doi-asserted-by":"crossref","unstructured":"Geisthovel, F., Frorath, B. and Brabant, G. (1996) Acarbose reduces elevated testosterone serum concentrations in hyperinsulinaemic premenopausal women: a pilot study. Hum. Reprod., 11, 2377\u20132381.","DOI":"10.1093\/oxfordjournals.humrep.a019118"},{"key":"key\n\t\t\t\t20170410032413_HOFFMANN-AND-COLCA-1992","doi-asserted-by":"crossref","unstructured":"Hoffmann, C.A. and Colca, J.R. (1992) New oral thiazolidinedione antidiabetic agents act as insulin sensitizers. Diabetes Care, 15, 1075\u20131078.","DOI":"10.2337\/diacare.15.8.1075"},{"key":"key\n\t\t\t\t20170410032413_IWAMOTO-ETAL-1991","doi-asserted-by":"crossref","unstructured":"Iwamoto, Y., Kuzuya, T., Matsuda, A. et al. (1991) Effect of new oral antidiabetic agent CS-045 on glucose tolerance and insulin secretion in patients with NIDDM. Diabetes Care, 14, 1083\u20131086.","DOI":"10.2337\/diacare.14.11.1083"},{"key":"key\n\t\t\t\t20170410032413_JAKUBOWICZ-AND-NESTLER-1997","doi-asserted-by":"crossref","unstructured":"Jakubowicz, D.J. and Nestler, J.E. (1997) 17\u03b1-hydroxyprogesterone response to leuprolide and serum androgens in obese women with and without polycystic ovary syndrome after dietary weight loss. J. Clin. Endocrinol. Metab., 82, 556\u2013560.","DOI":"10.1210\/jcem.82.2.3753"},{"key":"key\n\t\t\t\t20170410032413_KAHN-ETAL-1976","doi-asserted-by":"crossref","unstructured":"Kahn, C.R., Flier, J.S., Bar, R.S. et al. (1976) The syndromes of insulin resistance and acanthosis nigricans. Insulin-receptor disorders in men. N. Engl. J. Med., 294, 739\u2013745.","DOI":"10.1056\/NEJM197604012941401"},{"key":"key\n\t\t\t\t20170410032413_KIDDY-ETAL-1992","doi-asserted-by":"crossref","unstructured":"Kiddy, D.S., Hamilton-Fairley, D., Bush, A. et al. (1992) Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome. Clin. Endocrinol. (Oxf.), 36, 105\u2013111.","DOI":"10.1111\/j.1365-2265.1992.tb02909.x"},{"key":"key\n\t\t\t\t20170410032413_MARBACH-ETAL-1992","doi-asserted-by":"crossref","unstructured":"Marbach, P., Briner, U., Lemaire, M. et al. (1992) From somatostatin to sandostatin pharmacodynamics and pharmacokinetics. Metabolism, 41 (Suppl.), 7\u20139.","DOI":"10.1016\/0026-0495(92)90024-5"},{"key":"key\n\t\t\t\t20170410032413_MARSDEN-ETAL-1994","doi-asserted-by":"crossref","unstructured":"Marsden, P.J., Murdoch, A. and Taylor. (1994) Severe impairment of insulin action in adipocytes from amenorrheic subjects with polycystic ovary syndrome. Metabolism, 43, 1536\u20131542.","DOI":"10.1016\/0026-0495(94)90013-2"},{"key":"key\n\t\t\t\t20170410032413_MORALES-ETAL-1996","unstructured":"Morales, A.J., Laughlin, G.A., Butzow, T. et al. (1996) Insulin somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features. J. Clin. Endocrinol. Metab., 81, 2854\u20132864."},{"key":"key\n\t\t\t\t20170410032413_MORIN-PAPUNEN-ETAL-1998","doi-asserted-by":"crossref","unstructured":"Morin-Papunen, L.C., Koivunen, R.M., Ruokonen, A. et al. (1998) Metformin therapy improves the menstrual pattern with minimal endocrine and metabolic effects in women with polycystic ovary syndrome. Fertil. Steril., 69, 691\u2013696.","DOI":"10.1016\/S0015-0282(98)00011-9"},{"key":"key\n\t\t\t\t20170410032413_MORRIS-ETAL-1995","doi-asserted-by":"crossref","unstructured":"Morris, R.S., Carmina, E., Vijod, M.A. et al. (1995) Alterations in the sensitivity of serum insulin-like growth factor 1 and insulin like growth factor binding protein-3 to octreotide in polycystic ovary syndrome. Fertil. Steril., 63, 742\u2013746.","DOI":"10.1016\/S0015-0282(16)57475-5"},{"key":"key\n\t\t\t\t20170410032413_NAGI-AND-YUDKIN-1993","doi-asserted-by":"crossref","unstructured":"Nagi, D.K. and Yudkin, J.S. (1993) Effects of metformin on insulin resistance, risk factors for cardiovascular disease, and plasminogen activator inhibitor in NIDDM subjects: a study of two ethnic groups. Diabetes Care, 16, 621\u2013629.","DOI":"10.2337\/diacare.16.4.621"},{"key":"key\n\t\t\t\t20170410032413_NATIONAL-DIABETES-DATA-GROUP-1979","doi-asserted-by":"crossref","unstructured":"National Diabetes Data Group (1979) Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes, 28, 1039\u20131057.","DOI":"10.2337\/diab.28.12.1039"},{"key":"key\n\t\t\t\t20170410032413_NESTLER-1994","unstructured":"Nestler, J.E. (1994) Role of obesity and insulin in the development of anovulation. In Filicori, M. and Flamigni, C. (eds), Ovulation Induction: Basic Science and Clinical Advances. Elsevier, Amsterdam, The Netherlands, pp. 103\u2013114."},{"key":"key\n\t\t\t\t20170410032413_NESTLER-AND-JAKUBOWICZ-1997","unstructured":"Nestler, J.E. and Jakubowicz, D.J. (1997) Lean women with polycystic ovary syndrome respond to insulin reduction with decrease in ovarian P450c17 alpha activity and serum androgens. J. Clin. Endocrinol. Metab., 82, 4075\u20134079."},{"key":"key\n\t\t\t\t20170410032413_NESTLER-ETAL-1989","doi-asserted-by":"crossref","unstructured":"Nestler, J.E., Barlascini, C.O., Matt, D.W. et al. (1989) Suppression of serum insulin by Diazoxide reduces serum testosterone levels in obese women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab., 68, 1027\u20131032.","DOI":"10.1210\/jcem-68-6-1027"},{"key":"key\n\t\t\t\t20170410032413_NOLAN-ETAL-1994","doi-asserted-by":"crossref","unstructured":"Nolan, J.J., Ludvik, B., Beerdsen, P. et al. (1994) Improvement in glucose tolerance and insulin resistance in obese subject treated with troglitazone. N. Engl. J. Med., 31, 1188\u20131193.","DOI":"10.1056\/NEJM199411033311803"},{"key":"key\n\t\t\t\t20170410032413_OMEARA-ETAL-1993","unstructured":"O'Meara, N.M., Blackman, J.D., Ehrmann, D.A. et al. (1993) Defects in b- cell function in functional ovarian hyperandrogenism. J. Clin. Endocrinol. Metab., 76, 1241\u20131247."},{"key":"key\n\t\t\t\t20170410032413_OVESEN-AND-MOLLER-1997","unstructured":"Ovesen, P. and Moller, N. (1997) Hyperinsulinemia in lean PCO patients? In Filicori, M. and Flamigni, C. (eds), The Ovary: Regulation, Dysfunction and Treatment. The Proceedings of the 2nd World Conference on Ovulation Induction, Bologna, Italy 12\u201313 September, pp. 221\u2013228."},{"key":"key\n\t\t\t\t20170410032413_PLYMATE-ETAL-1988","doi-asserted-by":"crossref","unstructured":"Plymate, S.R., Matej, L.A., Jones, R.E. et al. (1988) Inhibition of sex hormone-binding globulin production in the human hepatoma (Hep G2) cell line by insulin and prolactin. J. Clin. Endocrinol. Metab., 67, 460\u2013464.","DOI":"10.1210\/jcem-67-3-460"},{"key":"key\n\t\t\t\t20170410032413_PORETSKY-1991","doi-asserted-by":"crossref","unstructured":"Poretsky, L. (1991) On the paradox of insulin-induced hyperandrogenism in insulin resistant states. Endocr. Rev., 12, 3\u201313.","DOI":"10.1210\/edrv-12-1-3"},{"key":"key\n\t\t\t\t20170410032413_PRELEVIC-ETAL-1990A","doi-asserted-by":"crossref","unstructured":"Prelevic, G.M., Wurzburger, M.I., Balint-Peric, L. et al. (1990a) Inhibitory effect of sandostatin on secretion of luteinising hormone and ovarian steroids in polycystic ovary syndrome. Lancet, 336, 900\u2013903.","DOI":"10.1016\/0140-6736(90)92270-R"},{"key":"key\n\t\t\t\t20170410032413_PRELEVIC-ETAL-1990B","doi-asserted-by":"crossref","unstructured":"Prelevic, G.M., Wurzburger, M.I. and Balint-Peric, L. (1990b) LH pulsatility and response to a single s.c. injection of buserelin in polycystic ovary syndrome. Gynecol. Endocrinol., 4, 1\u20133.","DOI":"10.3109\/09513599009030686"},{"key":"key\n\t\t\t\t20170410032413_SHOUPE-ETAL-1983","doi-asserted-by":"crossref","unstructured":"Shoupe, D., Kumar, D.D. and Lobo, R.A. (1983) Insulin resistance in polycystic ovary syndrome. Am. J. Obstet. Gynecol., 147, 588\u2013592.","DOI":"10.1016\/0002-9378(83)90023-6"},{"key":"key\n\t\t\t\t20170410032413_TOELLER-1991","unstructured":"Toeller, M. (1991) Modulation of intestinal glucose absorption: postponement of glucose absorption by alpha-glucosidase inhibitors. In Mogensen, C.E. and Standl, E. (eds), Pharmacology of Diabetes. Walter de Gruyter, Berlin, New York, pp. 123\u2013126."},{"key":"key\n\t\t\t\t20170410032413_VAN-DER-MEER-ETAL-1998","doi-asserted-by":"crossref","unstructured":"Van der Meer, M., de Boer, J.A., Hompes, P.G. et al. (1998) Octreotide, a somatostatin analogue, alters ovarian sensitivity to gonadotrophin stimulation as measured by the follicle stimulating hormone threshold in polycystic ovary syndrome. Hum. Reprod., 13, 1465\u20131469.","DOI":"10.1093\/humrep\/13.6.1465"},{"key":"key\n\t\t\t\t20170410032413_VELAZQUEZ-ETAL-1994","doi-asserted-by":"crossref","unstructured":"Velazquez, E.M., Mendoza, S., Hamer, T. et al. (1994) Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy. Metabolism, 43, 647\u2013654.","DOI":"10.1016\/0026-0495(94)90209-7"},{"key":"key\n\t\t\t\t20170410032413_WHITE-ETAL-1995","doi-asserted-by":"crossref","unstructured":"White, D., Leigh, A., Wilson, C. et al. (1995) Gonadotrophin and gonadal steroid response to a single dose of a long-acting agonist of gonadotrophin-releasing hormone in ovulatory and anovulatory women with polycystic ovary syndrome. Clin. Endocrinol. (Oxf.), 42, 475\u2013481.","DOI":"10.1111\/j.1365-2265.1995.tb02665.x"}],"container-title":["Human Reproduction"],"original-title":[],"language":"en","deposited":{"date-parts":[[2017,12,6]],"date-time":"2017-12-06T23:24:00Z","timestamp":1512602640000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/humrep\/article-lookup\/doi\/10.1093\/humrep\/14.12.2951"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,12]]},"references-count":50,"journal-issue":{"issue":"12","published-online":{"date-parts":[[1999,12]]},"published-print":{"date-parts":[[1999,12]]}},"URL":"https:\/\/doi.org\/10.1093\/humrep\/14.12.2951","relation":{},"ISSN":["1460-2350","0268-1161"],"issn-type":[{"value":"1460-2350","type":"electronic"},{"value":"0268-1161","type":"print"}],"subject":[],"published":{"date-parts":[[1999,12]]}}}